

Zolpidem (Ambien) is a prescription sleep aid used for insomnia. Learn about uses, dosage forms, who should avoid it, costs, and more in this 2026 guide.
Zolpidem is a non-benzodiazepine sedative-hypnotic medication — commonly called a "Z-drug" — prescribed for the short-term treatment of insomnia in adults who have difficulty falling asleep.
If you've been prescribed Zolpidem or are wondering whether it might help your sleep problems, this guide covers everything you need to know: what it is, how to take it, who should avoid it, and what it costs in 2026.
Zolpidem Tartrate is the generic name. It's sold under several brand names:
Zolpidem belongs to the non-benzodiazepine hypnotic class. It acts on the same GABA receptors in the brain as benzodiazepines but is more selective, targeting primarily the alpha-1 subunit involved in sedation. This selectivity is what gives it a somewhat different side effect profile compared to older sleep medications. For a plain-English explanation, see how Zolpidem works.
Ambien was originally manufactured by Sanofi-Aventis and received FDA approval in 1992. Generic Zolpidem became available in 2007 and is now made by multiple manufacturers, which helps keep costs low and availability high.
Zolpidem is classified as a Schedule IV controlled substance by the DEA. This means it has a recognized medical use but carries some potential for dependence and abuse. Your prescriptions may have quantity limits and refill restrictions.
Zolpidem is approved for the short-term treatment of insomnia, specifically difficulty falling asleep (sleep-onset insomnia). It is intended for use when insomnia is severe enough to require medical treatment.
Ambien CR (extended-release) has a two-layer design — one layer to help you fall asleep and a second that dissolves slowly to help you stay asleep. Intermezzo is designed specifically for people who wake up in the middle of the night and need at least 4 more hours of sleep time.
Some researchers have studied Zolpidem for disorders of consciousness (such as minimally conscious states), though this is not an FDA-approved use and is not common in routine practice.
Proper use of Zolpidem is critical for both safety and effectiveness:
Dosing depends on formulation, sex, and age:
The FDA lowered recommended doses for women in 2013 after research showed women metabolize Zolpidem more slowly, leading to higher morning blood levels.
Zolpidem is not safe for everyone. You should not take it if you:
Use caution if you:
Always give your doctor a complete list of your medications and health conditions. See our guide on Zolpidem drug interactions for details.
One of the advantages of Zolpidem is that it's available as an affordable generic.
Most insurance plans cover generic Zolpidem as a Tier 1 preferred generic, meaning low copays — often $0–$10. Some plans may impose quantity limits (typically 15–30 tablets per 30 days) or require prior authorization for brand-name or extended-release versions.
For more ways to save, check out our guide to Zolpidem coupons, discounts, and patient assistance programs.
Zolpidem is a well-established, effective sleep medication that has been helping people with insomnia since 1992. It comes in multiple formulations to match different sleep problems, and the generic version is both widely available and affordable. Like any medication, it works best when taken exactly as prescribed and under the guidance of your doctor.
If you have a prescription and need help finding a pharmacy with Zolpidem in stock, try Medfinder. And if you're still deciding whether Zolpidem is right for you, talk to your doctor — our guide on finding a doctor who prescribes Zolpidem can help you get started.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.